2020年11月03日

Rapid Vaccine Distribution to Over 7.5 Billion Humans

When a COVID-19 vaccine is developed and ready for distribution it will, in all likelihood, require cold chain services.

But, what environmental and economic costs will be attached to this logistical endeavour?

Who would have said a year ago that disruptions to supply chains, and more broadly, our way of life, would not come from a new company, a start-up, or a new economic model, but rather from a virus? The disruption caused by COVID-19 has been extensive, we cannot control its spread, and we do not understand its behaviour. How it affects our health varies from person to person for unknown reasons, and may include mild symptoms, severe symptoms, or even asymptotic cases in individuals who spread the virus unknowingly.

Let’s read the entire article.

This article is taken from Pharmaceutical Manufacturing and Packing Sourcer November 2020, pages 10-11. © Samedan Ltd

其他新闻

2022年6月23日

EMBALL'ISO的环保型等温包装现已成为日本通运的国际航空运输温度控制解决方案的一部分

EMBALL`ISO S.A.的子公司EMBALL`ISO JAPAN K.K. （总部：St-Georges-de-Reneins（法国），代表：Pierre CASOLI）宣布该公司的等温包装现已成为全球领先的物流公司之一以及日本第一大物流公司Nippon Express的物流解决方案的一部分。

继续浏览

2022年6月23日

EMBALL'ISO的环保型等温包装现已成为日本通运的国际航空运输温度控制解决方案的一部分

继续浏览

2021年5月10日

The logistics of a pandemic

As the pharmaceutical industry leapt up to meet the challenge of developing a vaccine to combat a global pandemic, its partners in the supply chain had to keep in step. Yann Martin, global sales director of isothermal solutions supplier EMBALL’ISO, tells us how the company ramped up its operations to cope with the surge in demand.

继续浏览

2021年2月23日

COVID-19 Vaccine Logistics Handbook

Discover how industry experts address the challenge of COVID-19 vaccine distribution and especially how EMBALL’ISO Reuse and Reverse Network can help make this distribution greener.

继续浏览